Demand for precise evaluations of the fibrosis and inflammatory tissue detectable in liver biopsy samples provides been fuelled by the need to understand the closest-to-real ramifications of new antiviral molecules on the lesions characterising the histological patterns of chronic viral, toxic, metabolic and autoimmune diseases. The existing scoring systems usually do not quantify these lesions, but only describe subjective classes of severity labelled with ordinal figures, and the available automated methods predicated on observer-computer interactions usually do not abolish observer subjectivity or use an inadequate measurement device, and take too long to analyse entire histological sections also. Related StoriesCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyUCSF-led researchers map out melanoma's genetic trajectoriesDiscovery may lead to advancement of cell-based regenerative therapy to restore thyroid functionA research article to be published on December 28, 2008 in the World Journal of Gastroenterology addresses this question.Second, it could probably help to decrease the bias in R&D funding, directing money to areas, such as for example improved vector control, that are recognized as more important for African countries. Third, it could help in creating a much-needed tradition of accountability and responsiveness in African politics, according to Tren . This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family members Foundation. Kaiser Health Information, an editorially independent information service, is a scheduled system of the Kaiser Family members Foundation, a nonpartisan health care policy research firm unaffiliated with Kaiser Permanente..